ZA923935B - New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments - Google Patents

New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments

Info

Publication number
ZA923935B
ZA923935B ZA923935A ZA923935A ZA923935B ZA 923935 B ZA923935 B ZA 923935B ZA 923935 A ZA923935 A ZA 923935A ZA 923935 A ZA923935 A ZA 923935A ZA 923935 B ZA923935 B ZA 923935B
Authority
ZA
South Africa
Prior art keywords
dihydropyridines
medicaments
cyano
amino
processes
Prior art date
Application number
ZA923935A
Other languages
English (en)
Inventor
D I Juergen Stoltefuss
I Juergen Stoltefuss D
Siegfried Goldmann
Goldmann Siegfried
Alexander Straub
Straub Alexander
Horst Boeshagen
Boeshagen Horst
Martin Bechem
Bechem Martin
Rainer Gross
Gross Rainer
Siegbert Hebisch
Hebisch Siegbert
Joachim Huetter
Huetter Joachim
Howard-Paul Rounding
Rounding Howard-Paul
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA923935B publication Critical patent/ZA923935B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA923935A 1991-05-30 1992-05-29 New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments ZA923935B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4117750A DE4117750A1 (de) 1991-05-30 1991-05-30 Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
ZA923935B true ZA923935B (en) 1993-02-24

Family

ID=6432811

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA923935A ZA923935B (en) 1991-05-30 1992-05-29 New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments

Country Status (22)

Country Link
US (3) US5225558A (xx)
EP (1) EP0515940B1 (xx)
JP (1) JPH05186459A (xx)
KR (1) KR920021530A (xx)
AT (1) ATE140455T1 (xx)
AU (2) AU656374B2 (xx)
CA (1) CA2069860A1 (xx)
CZ (1) CZ158692A3 (xx)
DE (2) DE4117750A1 (xx)
DK (1) DK0515940T3 (xx)
ES (1) ES2089286T3 (xx)
FI (1) FI922428A (xx)
GR (1) GR3020575T3 (xx)
HU (2) HUT61538A (xx)
IE (1) IE921771A1 (xx)
IL (3) IL102032A (xx)
MX (1) MX9202366A (xx)
NO (2) NO921906L (xx)
NZ (2) NZ242932A (xx)
RU (1) RU2081872C1 (xx)
SK (1) SK158692A3 (xx)
ZA (1) ZA923935B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2683819B1 (fr) * 1991-10-28 1994-02-11 Synthelabo Derives de quinoleine, leur procede de preparation et leur application en therapeutique.
ES2113933T3 (es) * 1991-11-12 1998-05-16 Coatex Sa Agente de trituracion y/o dispersion a base de polimeros y/o copolimeros neutralizados parcialmente por magnesio para suspensiones acuosas de materiales minerales para la aplicacion de pigmentos.
DE4233586A1 (de) * 1992-10-06 1994-04-07 Bayer Ag 3-Imino-3-alkoxy-propionsäurelactate und deren tautomere Acrylsäurelactate
DE4313693A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2-Amino-4-chinolin-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung
DE4313695A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2-Amino-5-cyano-4-chinolyldihydropyridinester, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4313691A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2,6-Disubstituierte 4-Chinolyl-dihydropyridine
DE4313697A1 (de) * 1993-04-27 1994-11-03 Bayer Ag Chinolyl-dihydropyridinester, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4313696A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2-Amino-4-heteroaryl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4313692A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 3-Chinolyl substituierte Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4432378A1 (de) * 1994-09-12 1996-03-14 Bayer Ag Injizierbare liposomale Arzneizubereitungen

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2359329A (en) * 1943-06-18 1944-10-03 Burroughs Wellcome Co Quinoline substituted dihydropyridines
US4001258A (en) * 1972-03-06 1977-01-04 Bayer Aktiengesellschaft 2-amino-1,4-dihydropyridine derivatives
US3996234A (en) * 1972-04-18 1976-12-07 Bayer Aktiengesellschaft 1,4-Dihydropyridine carboxylic acid esters
DE2242786A1 (de) * 1972-08-31 1974-03-14 Bayer Ag Verfahren zur herstellung von neuen 2-amino-1,4-dihydropyridinen mit einer carbonylfunktion sowie ihre verwendung als arzneimittel
US3989708A (en) * 1972-08-31 1976-11-02 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
DE2310747A1 (de) * 1973-03-03 1974-09-12 Bayer Ag Verfahren zur herstellung von neuen amino-3,4-dihydropyridinen und ihre verwendung als arzneimittel
US4002762A (en) * 1973-03-03 1977-01-11 Bayer Aktiengesellschaft 2-Amino-3,4-dihydropyridines used to effect coronary vessel dilation and treat hypertension
DE2412750A1 (de) * 1974-03-16 1975-09-18 Bayer Ag Verfahren zur herstellung von 4-amino2,2,6,6-tetramethyl-piperidin
DE2623170C2 (de) * 1976-05-22 1982-03-11 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von α-Cyanzimtaldehyd-Derivaten und 3,4,5-Trimethoxy-α-Cyanzimtaldehyd
DE2658804A1 (de) * 1976-12-24 1978-07-06 Bayer Ag Kreislaufbeeinflussende mittel
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
DE3015219A1 (de) * 1980-04-19 1981-10-22 Bayer Ag, 5090 Leverkusen 6-amino-4,5-dihydropyridin-3-carbonsaeureester, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3134945A1 (de) * 1981-09-03 1983-03-17 Bayer Ag, 5090 Leverkusen Substituierte 2-amino-3,4-dihydropyridinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimittel
US5001381A (en) * 1987-12-08 1991-03-19 Akio Takahashi Electro-static motor
DE4011105A1 (de) * 1990-04-06 1991-10-10 Bayer Ag Neue 4-chinolyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
SK158692A3 (en) 1995-03-08
FI922428A (fi) 1992-12-01
DE59206772D1 (de) 1996-08-22
US5432282A (en) 1995-07-11
NZ242932A (en) 1995-06-27
NO970573D0 (no) 1997-02-07
IL116384A (en) 1996-10-16
NO921906L (no) 1992-12-01
CZ158692A3 (en) 1993-07-14
IE921771A1 (en) 1992-12-02
HUT61538A (en) 1993-01-28
HU9201799D0 (en) 1992-08-28
EP0515940A1 (de) 1992-12-02
DE4117750A1 (de) 1992-12-24
AU1604592A (en) 1992-12-03
US5225558A (en) 1993-07-06
IL102032A (en) 1996-06-18
IL116384A0 (en) 1996-03-31
RU2081872C1 (ru) 1997-06-20
US5380851A (en) 1995-01-10
DK0515940T3 (da) 1996-11-25
JPH05186459A (ja) 1993-07-27
HU211579A9 (en) 1995-12-28
FI922428A0 (fi) 1992-05-27
ATE140455T1 (de) 1996-08-15
MX9202366A (es) 1992-11-01
EP0515940B1 (de) 1996-07-17
NO970573L (no) 1992-12-01
IL102032A0 (en) 1992-12-30
NZ264151A (en) 1995-06-27
GR3020575T3 (en) 1996-10-31
AU1619995A (en) 1995-08-03
AU656374B2 (en) 1995-02-02
CA2069860A1 (en) 1992-12-01
ES2089286T3 (es) 1996-10-01
NO921906D0 (no) 1992-05-14
KR920021530A (ko) 1992-12-18

Similar Documents

Publication Publication Date Title
MX9700538A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares.
IL125282A (en) Substituted imidazole compounds, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating cytokine mediated diseases
MY106272A (en) Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants.
TW352384B (en) Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
AP9801392A0 (en) Concentrated antibody preparation.
NZ251320A (en) Bis-aromatic alpha,beta-unsaturated ketones, preparation and use in pharmaceutical compositions
MX9705296A (es) Compuestos novedosos de imidazol 1,4,5-susbtituidos y el uso de los mismos para preparar composiciones para uso en terapia.
ES8801243A1 (es) Procedimiento para la obtencion de medicamentos que contienen 1-heteroaril-4--aril-pirazolin-5-onas.
CA2176298A1 (en) A single high dose fluoroquinolone treatment
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
ZA923935B (en) New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
BG105275A (en) Tan-1057 derivatives
ES8707488A1 (es) Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
IE870577L (en) Topical amide preparation
ES8404693A1 (es) Procedimiento de preparacion de nuevos amino-14 esteroides.
UA39179C2 (uk) Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, спосіб її одержання та антиаритмічний лікарський засіб
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
IT8721540A0 (it) Composizioni farmaceutiche contenenti trapidil, loro procedimento di preparazione erelativo impiego terapeutico.
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
MY103584A (en) 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it